The coprimary end points were the changes from baseline in the total nasal-polyp score (range, 0 to 4 [for each nostril]; higher scores indicate greater severity) and the mean nasal-congestion ...

"And depemokimab appears to be safe in our patients with nasal polyp." Adverse events, while common, occurred at a similar rate between depemokimab and placebo in both ANCHOR-1 (74% vs 79% ) and ...

Even professionals usually need to sedate a cat before poking around their nose. The typical treatment for nasal blockages is ... find the trapped object or polyp, they may use a tiny hook or ...

The monoclonal antibody against thymic stromal lymphopoietin (TSLP) improved total nasal-polyp score by a mean -2.07 points (95% CI −2.39 to −1.74) more than placebo on a 0-4 point scale at 52 ...

which results in the growth of nasal polyps in the nose that can sometimes require surgical intervention. In severe cases, polyps recur, so patients have to undergo multiple operations.

Phase 3 trials showed significant improvements in nasal polyp size and obstruction. Volatility can create massive trading opportunities—if you know how to capitalize on it. On Sunday ...

(RTTNews) - The Phase III WAYPOINT trial results revealed that AstraZeneca (AZN.L, AZN) and Amgen's (AMGN) TEZSPIRE (tezepelumab-ekko) significantly decreased nasal polyp severity, reduced the ...